Literature DB >> 8509161

The inhibition of oligodendrocytic differentiation of O-2A progenitors caused by basic fibroblast growth factor is overridden by astrocytes.

M Mayer1, O Bögler, M Noble.   

Abstract

The inhibition of differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitors into oligodendrocytes caused by basic fibroblast growth factor (bFGF) can be overcome by non-O-2A lineage cells present in the optic nerve and by astrocytes purified from cerebral cortices. Although purified O-2A progenitors grown in the presence of bFGF for up to 6 days were inhibited from differentiating into oligodendrocytes, O-2A progenitors growing in heterogeneous optic nerve cultures did not show a similar inhibition of differentiation. The factor(s) responsible for overriding the inhibitory effects of bFGF appeared to be secreted by astrocytes, as extensive generation of oligodendrocytes was seen in cultures of purified O-2A progenitors exposed to bFGF+ medium conditioned by purified astrocytes (ACM). In addition, purified O-2A progenitors displayed a remarkable sensitivity to bFGF, which extended at least down to concentrations of 0.03 ng/ml, a concentration of < 2 x 10(-12) M. At a bFGF concentration of just 0.1 ng/ml, this mitogen still promoted DNA synthesis in as many O-2A progenitors as in cultures exposed to 1-30 ng/ml of this growth factor, but exhibited a reduced ability to promote DNA synthesis in oligodendrocytes. In addition, although concentrations of bFGF as low as 0.03 ng/ml were a potent stimulator of DNA synthesis in O-2A progenitors, application of this amount of bFGF no longer inhibited the differentiation of progenitors into oligodendrocytes as effectively as application of higher bFGF concentrations. Thus, the induction of DNA synthesis by bFGF can be uncoupled from the inhibition of differentiation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8509161     DOI: 10.1002/glia.440080103

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  12 in total

Review 1.  Regulation of oligodendrocyte development.

Authors:  D M Orentas; R H Miller
Journal:  Mol Neurobiol       Date:  1998-12       Impact factor: 5.590

2.  A role for the acetylcholine receptor-inducing protein ARIA in oligodendrocyte development.

Authors:  T Vartanian; G Corfas; Y Li; G D Fischbach; K Stefansson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

Review 3.  Glial lineages and myelination in the central nervous system.

Authors:  A Compston; J Zajicek; J Sussman; A Webb; G Hall; D Muir; C Shaw; A Wood; N Scolding
Journal:  J Anat       Date:  1997-02       Impact factor: 2.610

Review 4.  Growth factors: potential therapeutic applications in neurology.

Authors:  J Drago; T J Kilpatrick; S A Koblar; P S Talman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

Review 5.  Growth factors, glia and gliomas.

Authors:  M Noble; M Mayer-Pröschel
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

6.  Nerve growth factor plays a divergent role in mediating growth of rat C6 glioma cells via binding to the p75 neurotrophin receptor.

Authors:  Carla Weis; Bettina Wiesenhofer; Christian Humpel
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

7.  Quantitative temporal proteomic analysis of human embryonic stem cell differentiation into oligodendrocyte progenitor cells.

Authors:  Raghothama Chaerkady; Brian Letzen; Santosh Renuse; Nandini A Sahasrabuddhe; Praveen Kumar; Angelo H All; Nitish V Thakor; Bernard Delanghe; John D Gearhart; Akhilesh Pandey; Candace L Kerr
Journal:  Proteomics       Date:  2011-09-02       Impact factor: 3.984

8.  Chronically increased ciliary neurotrophic factor and fibroblast growth factor-2 expression after spinal contusion in rats.

Authors:  Richa B Tripathi; Dana M McTigue
Journal:  J Comp Neurol       Date:  2008-09-10       Impact factor: 3.215

9.  N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro.

Authors:  M Mayer; M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

10.  Better prognosis of patients with glioma expressing FGF2-dependent PDGFRA irrespective of morphological diagnosis.

Authors:  Dongfeng Chen; Annette Persson; Yingyu Sun; Leif G Salford; David Gisselsson Nord; Elisabet Englund; Tao Jiang; Xiaolong Fan
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.